Evidence map›Paper›PMID 35504971›Full record

ArticleNature2022

Publisher Correction: Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.

Martin A M Reijns, David A Parry, Thomas C Williams, Ferran Nadeu, Rebecca L Hindshaw, Diana O Rios Szwed, Michael D Nicholson, Paula Carroll, Shelagh Boyle, Romina Royo and 12 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Martin A M Reijns *Disease Mechanisms, MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK. martin.reijns@ed.ac.uk.ORCID http://orcid.org/0000-0002-5048-2752
David A Parry *Disease Mechanisms, MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-0376-7736
Thomas C Williams *Disease Mechanisms, MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-3866-1344
Ferran NadeuInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID http://orcid.org/0000-0003-2910-9440
Rebecca L HindshawInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Diana O Rios SzwedDisease Mechanisms, MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-0893-6324
Michael D NicholsonCancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-2813-8979
Paula CarrollDisease Mechanisms, MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.
Shelagh BoyleGenome Regulation, MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.
Romina RoyoBarcelona Supercomputing Center (BSC), Barcelona, Spain.
Alex J CornishThe Institute of Cancer Research, London, UK.ORCID http://orcid.org/0000-0002-3966-3501
Hang XiangInstitute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
Kate RidoutDepartment of Oncology, University of Oxford, Oxford, UK.
Genomics England Research Consortium
Colorectal Cancer Domain UK 100,000 Genomes Project
Anna SchuhDepartment of Oncology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-3938-8490
Konrad AdenInstitute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
Claire PallesInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-9670-2263
Elias CampoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID http://orcid.org/0000-0001-9850-9793
Tatjana StankovicInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-3780-274X
Martin S TaylorBiomedical Genomics, MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK. martin.taylor@ed.ac.uk.ORCID http://orcid.org/0000-0001-7656-330X
Andrew P JacksonDisease Mechanisms, MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK. andrew.jackson@ed.ac.uk.ORCID http://orcid.org/0000-0002-8739-2646

Funding

Cancer Research UK 19771Cancer Research UK 25514Medical Research Council MC_EX_MR/M009203/1Medical Research Council MC_PC_14089Medical Research Council MR/M009203/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35504971
PMCPMC9117124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.